1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Biodefense Market, By Product
5.1 Introduction
5.2 Anthrax
5.3 Botulism
5.4 Cholera
5.5 Influenza
5.6 Nuclear
5.7 Smallpox
5.8 Other Products
6 Global Biodefense Market, By Detection Device
6.1 Introduction
6.2 Assays
6.3 Identifiers
6.4 Samplers
6.5 Detectors
6.6 Triggering Devices
6.7 Other Detection Devices
7 Global Biodefense Market, By Application
7.1 Introduction
7.2 Military
7.3 Civilian
8 Global Biodefense Market, By End User
8.1 Introduction
8.2 Hospitals & Clinics
8.3 Ambulatory Care Centers
8.4 Government Institutions
8.5 Other End Users
9 Global Biodefense Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Siga Technologies Inc.
11.2 Emergent BioSolutions Inc.
11.3 Ichor Medical Systems
11.4 National Resilience, Inc.
11.5 Bavarian Nordic
11.6 Dynavax Technologies
11.7 Nighthawk Biosciences, Inc.
11.8 XOMA Corporation
11.9 Dynport Vaccine Company
11.10 Cleveland Biolabs
11.11 Ology Bioservices
11.12 Alnylam Pharmaceuticals Inc.
11.13 XOMA corporation
11.14 Altimmune Inc.
11.15 Biosearch Technologies
11.16 Bruker Detection
List of Tables
Table 1 Global Biodefense Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Biodefense Market Outlook, By Product (2021-2030) ($MN)
Table 3 Global Biodefense Market Outlook, By Anthrax (2021-2030) ($MN)
Table 4 Global Biodefense Market Outlook, By Botulism (2021-2030) ($MN)
Table 5 Global Biodefense Market Outlook, By Cholera (2021-2030) ($MN)
Table 6 Global Biodefense Market Outlook, By Influenza (2021-2030) ($MN)
Table 7 Global Biodefense Market Outlook, By Nuclear (2021-2030) ($MN)
Table 8 Global Biodefense Market Outlook, By Smallpox (2021-2030) ($MN)
Table 9 Global Biodefense Market Outlook, By Other Products (2021-2030) ($MN)
Table 10 Global Biodefense Market Outlook, By Detection Device (2021-2030) ($MN)
Table 11 Global Biodefense Market Outlook, By Assays (2021-2030) ($MN)
Table 12 Global Biodefense Market Outlook, By Identifiers (2021-2030) ($MN)
Table 13 Global Biodefense Market Outlook, By Samplers (2021-2030) ($MN)
Table 14 Global Biodefense Market Outlook, By Detectors (2021-2030) ($MN)
Table 15 Global Biodefense Market Outlook, By Triggering Devices (2021-2030) ($MN)
Table 16 Global Biodefense Market Outlook, By Other Detection Devices (2021-2030) ($MN)
Table 17 Global Biodefense Market Outlook, By Application (2021-2030) ($MN)
Table 18 Global Biodefense Market Outlook, By Military (2021-2030) ($MN)
Table 19 Global Biodefense Market Outlook, By Civilian (2021-2030) ($MN)
Table 20 Global Biodefense Market Outlook, By End User (2021-2030) ($MN)
Table 21 Global Biodefense Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
Table 22 Global Biodefense Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
Table 23 Global Biodefense Market Outlook, By Government Institutions (2021-2030) ($MN)
Table 24 Global Biodefense Market Outlook, By Other End Users (2021-2030) ($MN)
Table 25 North America Biodefense Market Outlook, By Country (2021-2030) ($MN)
Table 26 North America Biodefense Market Outlook, By Product (2021-2030) ($MN)
Table 27 North America Biodefense Market Outlook, By Anthrax (2021-2030) ($MN)
Table 28 North America Biodefense Market Outlook, By Botulism (2021-2030) ($MN)
Table 29 North America Biodefense Market Outlook, By Cholera (2021-2030) ($MN)
Table 30 North America Biodefense Market Outlook, By Influenza (2021-2030) ($MN)
Table 31 North America Biodefense Market Outlook, By Nuclear (2021-2030) ($MN)
Table 32 North America Biodefense Market Outlook, By Smallpox (2021-2030) ($MN)
Table 33 North America Biodefense Market Outlook, By Other Products (2021-2030) ($MN)
Table 34 North America Biodefense Market Outlook, By Detection Device (2021-2030) ($MN)
Table 35 North America Biodefense Market Outlook, By Assays (2021-2030) ($MN)
Table 36 North America Biodefense Market Outlook, By Identifiers (2021-2030) ($MN)
Table 37 North America Biodefense Market Outlook, By Samplers (2021-2030) ($MN)
Table 38 North America Biodefense Market Outlook, By Detectors (2021-2030) ($MN)
Table 39 North America Biodefense Market Outlook, By Triggering Devices (2021-2030) ($MN)
Table 40 North America Biodefense Market Outlook, By Other Detection Devices (2021-2030) ($MN)
Table 41 North America Biodefense Market Outlook, By Application (2021-2030) ($MN)
Table 42 North America Biodefense Market Outlook, By Military (2021-2030) ($MN)
Table 43 North America Biodefense Market Outlook, By Civilian (2021-2030) ($MN)
Table 44 North America Biodefense Market Outlook, By End User (2021-2030) ($MN)
Table 45 North America Biodefense Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
Table 46 North America Biodefense Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
Table 47 North America Biodefense Market Outlook, By Government Institutions (2021-2030) ($MN)
Table 48 North America Biodefense Market Outlook, By Other End Users (2021-2030) ($MN)
Table 49 Europe Biodefense Market Outlook, By Country (2021-2030) ($MN)
Table 50 Europe Biodefense Market Outlook, By Product (2021-2030) ($MN)
Table 51 Europe Biodefense Market Outlook, By Anthrax (2021-2030) ($MN)
Table 52 Europe Biodefense Market Outlook, By Botulism (2021-2030) ($MN)
Table 53 Europe Biodefense Market Outlook, By Cholera (2021-2030) ($MN)
Table 54 Europe Biodefense Market Outlook, By Influenza (2021-2030) ($MN)
Table 55 Europe Biodefense Market Outlook, By Nuclear (2021-2030) ($MN)
Table 56 Europe Biodefense Market Outlook, By Smallpox (2021-2030) ($MN)
Table 57 Europe Biodefense Market Outlook, By Other Products (2021-2030) ($MN)
Table 58 Europe Biodefense Market Outlook, By Detection Device (2021-2030) ($MN)
Table 59 Europe Biodefense Market Outlook, By Assays (2021-2030) ($MN)
Table 60 Europe Biodefense Market Outlook, By Identifiers (2021-2030) ($MN)
Table 61 Europe Biodefense Market Outlook, By Samplers (2021-2030) ($MN)
Table 62 Europe Biodefense Market Outlook, By Detectors (2021-2030) ($MN)
Table 63 Europe Biodefense Market Outlook, By Triggering Devices (2021-2030) ($MN)
Table 64 Europe Biodefense Market Outlook, By Other Detection Devices (2021-2030) ($MN)
Table 65 Europe Biodefense Market Outlook, By Application (2021-2030) ($MN)
Table 66 Europe Biodefense Market Outlook, By Military (2021-2030) ($MN)
Table 67 Europe Biodefense Market Outlook, By Civilian (2021-2030) ($MN)
Table 68 Europe Biodefense Market Outlook, By End User (2021-2030) ($MN)
Table 69 Europe Biodefense Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
Table 70 Europe Biodefense Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
Table 71 Europe Biodefense Market Outlook, By Government Institutions (2021-2030) ($MN)
Table 72 Europe Biodefense Market Outlook, By Other End Users (2021-2030) ($MN)
Table 73 Asia Pacific Biodefense Market Outlook, By Country (2021-2030) ($MN)
Table 74 Asia Pacific Biodefense Market Outlook, By Product (2021-2030) ($MN)
Table 75 Asia Pacific Biodefense Market Outlook, By Anthrax (2021-2030) ($MN)
Table 76 Asia Pacific Biodefense Market Outlook, By Botulism (2021-2030) ($MN)
Table 77 Asia Pacific Biodefense Market Outlook, By Cholera (2021-2030) ($MN)
Table 78 Asia Pacific Biodefense Market Outlook, By Influenza (2021-2030) ($MN)
Table 79 Asia Pacific Biodefense Market Outlook, By Nuclear (2021-2030) ($MN)
Table 80 Asia Pacific Biodefense Market Outlook, By Smallpox (2021-2030) ($MN)
Table 81 Asia Pacific Biodefense Market Outlook, By Other Products (2021-2030) ($MN)
Table 82 Asia Pacific Biodefense Market Outlook, By Detection Device (2021-2030) ($MN)
Table 83 Asia Pacific Biodefense Market Outlook, By Assays (2021-2030) ($MN)
Table 84 Asia Pacific Biodefense Market Outlook, By Identifiers (2021-2030) ($MN)
Table 85 Asia Pacific Biodefense Market Outlook, By Samplers (2021-2030) ($MN)
Table 86 Asia Pacific Biodefense Market Outlook, By Detectors (2021-2030) ($MN)
Table 87 Asia Pacific Biodefense Market Outlook, By Triggering Devices (2021-2030) ($MN)
Table 88 Asia Pacific Biodefense Market Outlook, By Other Detection Devices (2021-2030) ($MN)
Table 89 Asia Pacific Biodefense Market Outlook, By Application (2021-2030) ($MN)
Table 90 Asia Pacific Biodefense Market Outlook, By Military (2021-2030) ($MN)
Table 91 Asia Pacific Biodefense Market Outlook, By Civilian (2021-2030) ($MN)
Table 92 Asia Pacific Biodefense Market Outlook, By End User (2021-2030) ($MN)
Table 93 Asia Pacific Biodefense Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
Table 94 Asia Pacific Biodefense Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
Table 95 Asia Pacific Biodefense Market Outlook, By Government Institutions (2021-2030) ($MN)
Table 96 Asia Pacific Biodefense Market Outlook, By Other End Users (2021-2030) ($MN)
Table 97 South America Biodefense Market Outlook, By Country (2021-2030) ($MN)
Table 98 South America Biodefense Market Outlook, By Product (2021-2030) ($MN)
Table 99 South America Biodefense Market Outlook, By Anthrax (2021-2030) ($MN)
Table 100 South America Biodefense Market Outlook, By Botulism (2021-2030) ($MN)
Table 101 South America Biodefense Market Outlook, By Cholera (2021-2030) ($MN)
Table 102 South America Biodefense Market Outlook, By Influenza (2021-2030) ($MN)
Table 103 South America Biodefense Market Outlook, By Nuclear (2021-2030) ($MN)
Table 104 South America Biodefense Market Outlook, By Smallpox (2021-2030) ($MN)
Table 105 South America Biodefense Market Outlook, By Other Products (2021-2030) ($MN)
Table 106 South America Biodefense Market Outlook, By Detection Device (2021-2030) ($MN)
Table 107 South America Biodefense Market Outlook, By Assays (2021-2030) ($MN)
Table 108 South America Biodefense Market Outlook, By Identifiers (2021-2030) ($MN)
Table 109 South America Biodefense Market Outlook, By Samplers (2021-2030) ($MN)
Table 110 South America Biodefense Market Outlook, By Detectors (2021-2030) ($MN)
Table 111 South America Biodefense Market Outlook, By Triggering Devices (2021-2030) ($MN)
Table 112 South America Biodefense Market Outlook, By Other Detection Devices (2021-2030) ($MN)
Table 113 South America Biodefense Market Outlook, By Application (2021-2030) ($MN)
Table 114 South America Biodefense Market Outlook, By Military (2021-2030) ($MN)
Table 115 South America Biodefense Market Outlook, By Civilian (2021-2030) ($MN)
Table 116 South America Biodefense Market Outlook, By End User (2021-2030) ($MN)
Table 117 South America Biodefense Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
Table 118 South America Biodefense Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
Table 119 South America Biodefense Market Outlook, By Government Institutions (2021-2030) ($MN)
Table 120 South America Biodefense Market Outlook, By Other End Users (2021-2030) ($MN)
Table 121 Middle East & Africa Biodefense Market Outlook, By Country (2021-2030) ($MN)
Table 122 Middle East & Africa Biodefense Market Outlook, By Product (2021-2030) ($MN)
Table 123 Middle East & Africa Biodefense Market Outlook, By Anthrax (2021-2030) ($MN)
Table 124 Middle East & Africa Biodefense Market Outlook, By Botulism (2021-2030) ($MN)
Table 125 Middle East & Africa Biodefense Market Outlook, By Cholera (2021-2030) ($MN)
Table 126 Middle East & Africa Biodefense Market Outlook, By Influenza (2021-2030) ($MN)
Table 127 Middle East & Africa Biodefense Market Outlook, By Nuclear (2021-2030) ($MN)
Table 128 Middle East & Africa Biodefense Market Outlook, By Smallpox (2021-2030) ($MN)
Table 129 Middle East & Africa Biodefense Market Outlook, By Other Products (2021-2030) ($MN)
Table 130 Middle East & Africa Biodefense Market Outlook, By Detection Device (2021-2030) ($MN)
Table 131 Middle East & Africa Biodefense Market Outlook, By Assays (2021-2030) ($MN)
Table 132 Middle East & Africa Biodefense Market Outlook, By Identifiers (2021-2030) ($MN)
Table 133 Middle East & Africa Biodefense Market Outlook, By Samplers (2021-2030) ($MN)
Table 134 Middle East & Africa Biodefense Market Outlook, By Detectors (2021-2030) ($MN)
Table 135 Middle East & Africa Biodefense Market Outlook, By Triggering Devices (2021-2030) ($MN)
Table 136 Middle East & Africa Biodefense Market Outlook, By Other Detection Devices (2021-2030) ($MN)
Table 137 Middle East & Africa Biodefense Market Outlook, By Application (2021-2030) ($MN)
Table 138 Middle East & Africa Biodefense Market Outlook, By Military (2021-2030) ($MN)
Table 139 Middle East & Africa Biodefense Market Outlook, By Civilian (2021-2030) ($MN)
Table 140 Middle East & Africa Biodefense Market Outlook, By End User (2021-2030) ($MN)
Table 141 Middle East & Africa Biodefense Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
Table 142 Middle East & Africa Biodefense Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
Table 143 Middle East & Africa Biodefense Market Outlook, By Government Institutions (2021-2030) ($MN)
Table 144 Middle East & Africa Biodefense Market Outlook, By Other End Users (2021-2030) ($MN)
| ※参考情報 バイオディフェンスとは、生物学的脅威から国家や社会を守るための一連の防御策を指します。これには、細菌、ウイルス、毒素などによる生物テロや感染症の流行に対する予防、検出、対応が含まれます。バイオディフェンスは公共の健康を守るだけでなく、国家の安全保障にも直結する重要な分野です。 バイオディフェンスにはいくつかの種類があります。まず、予防措置が挙げられます。これには、ワクチン接種や抗ウイルス薬の投与、感染症対策の教育などが含まれます。特に、特定の病原体に対するワクチン開発は、将来のアウトブレイクを防ぐために非常に重要です。また、健康監視システムを構築することで、感染症の早期発見と迅速な対応が可能となります。 次に、検出技術が重要です。迅速検査キットや分子生物学的手法を利用した病原体の特定は、感染の拡大を防ぐ上で不可欠です。具体的には、PCR（ポリメラーゼ連鎖反応）や次世代シーケンシング技術を用いることで、感染者の早期発見が可能となります。これらの技術は、迅速な診断とそれに基づく公衆衛生対策に直接影響します。 また、感染症が発生した際の対応策もバイオディフェンスの一部です。感染が確認された場合には、隔離措置やコンタクトトレーシングを行うことが求められます。これにより感染拡大を抑えることができ、公共の健康を守ることができます。さらに、緊急時には医療資源を適切に配分し、医療従事者への教育や訓練を行うことも重要です。 バイオディフェンスには関連技術も多岐にわたります。例えば、情報技術の進展により、データ解析や人工知能（AI）を用いた予測モデルが発展しています。このような技術は、感染症の流行予測や早期警戒システムの構築に役立っています。また、リモートシンダイナミクスや地理情報システム（GIS）を利用した地理的なデータ解析も、感染症の広がりを可視化する上で重要です。 国際的な協力もバイオディフェンスには欠かせません。感染症は国境を越えて広がるため、国際的な情報共有や連携が必要です。WHO（世界保健機関）や各国の公衆衛生機関との協力体制を築くことによって、世界的なバイオディフェンスの強化につながります。共同での研究開発や訓練、資源の共有も重要です。 バイオディフェンスに関連する法律や政策も考慮する必要があります。国家として考えるとき、規制や法律に基づいた防衛策の整備が求められます。また、倫理的な観点からも、個人のプライバシーや自由とのバランスを考慮することが不可欠です。公衆衛生政策は、個人の権利と公共の健康との間で適切な越界を持つべきです。 最後に、バイオディフェンスの進展は世界的な課題でもあります。感染症のリスクは常に存在しており、新たな病原体が登場する可能性も考えられます。そのため、バイオディフェンスは単なる国家の枠を超えたグローバルな取り組みであるべきです。今後の研究や技術の発展により、効果的な対策が模索されることが期待されています。このようにして、私たちの社会は生物学的脅威に対する耐性を強化していくことができるのです。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
